Hjem › Endetarmskreft › Washington
Kliniske studier for Endetarmskreft i Washington
9 studier for Endetarmskreft søker deltakere på steder i Washington.
Byer i Washington
Offisiell studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939Family Communications After Genetic Testing
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- og 17 flere
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Fred Hutchinson Cancer Center ( Site 0076), Seattle
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997497Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
- Fred Hutch, Seattle
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05081024Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Valley Medical Center, Renton
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima
Rekrutterer
Alder 45 til 70 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05080673Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- FHCC Overlake, Bellevue
- FHCC at EvergreenHealth, Kirkland
- Virginia Mason Medical Center, Seattle
- og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT06205485A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06051695SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Fred Hutch Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT06682793Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.